Latest news for FBR (OTC:FBRKF) Stock

FBR Ltd is the inventor of the Hadrian X, an automated end-to-end bricklaying robot. It functions as a 3D printer and builds brick structures in situ, course by course, using adhesive to bond the bricks together. The Hadrian X is capable of working in outdoor environments due to Dynamic Stabilisation Technology (DST) which rapidly measures and adjusts for dynamic interference caused by uncontrolled environmental conditions. Geographically, it only operates in Australia.

News

Intraday Update

Markets

Movers

Trading Ideas

AAEEF

AAVMY

ABEV

ABGSF

ABMD

ABTX

ACCFF

ACCYY

ACHV

ACNB

ACRFF

ACRGF

ACSAY

ACST

ACTG

ADMA

ADTN

ADVZF

AERI

AFLYY

AGCO

AGEEF

AGESY

AGLXY

AHFD

AHKSY

AHOTF

AICAF

AINV

AIPUY

AIRG

AIRYY

AISSF

AKO-A

AKZOY

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALEX

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALLY

ALOT

ALSN

ALTM

ALXEF

ALXN

AMCR

AMHPF

AMKBF

AMKBY

AMNB

AMPH

AMRN

AMSLF

ANAT

ANGO

ANIP

Australia and New Zealand Banking Group Limited

ANZBY

ANZFF

APELY

APEX

APHA

APTS

ARCB

ARCC

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARRRF

Stocks That Hit 52-Week Lows On Friday

Movers & Shakers

General

ACNNF

AEMD

AESE

AGHI

AKER

AMCX

AMRH

AMRK

ANDR

APAAF

ATADF

BNKPF

BOSC

BRGO

CADMF

CFWFF

CHKIF

CLXT

CNGGF

CPPMF

CPYT

DELRF

DIALF

DLPN

DLUEY

DTNOF

ECIFY

EGRAF

EVLO

FDMF

FITX

GARB

GDRZF

GLOP

GMHLF

GNAL

GOHE

GRSO

GTBP

HAON

HENC

HGHAF

HHPHF

HVBTF

IDXG

IMBBY

IMTV

INAP

INDXF

INND

INNMF

IPIX

JBFCF

JBFCY

JWCAF

KBSF

KWBT

LKCO

LTBR

LUCRF

GLOBALIVE TECH INC by Globalive Technology Inc.

LVVEF

MCEP

MDTR

MFST

MREO

MRIN

MTFB

NIMU

NOHO

NRGMF

NWCI

OCGN

PHVAF

PMGYF

PPCLY

PRGX

PRLE

PTNYF

PXPP

PZRXQ

RCKHF

RLBD

RMHB

RVSDF

SCNNF

SITO

SNDL

SNOA

SPLIF

SQNS

Stocks That Hit 52-Week Lows On Tuesday

FBR Ltd

Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.27) by 11.11 percent. This is a 33.33 percent increase over losses of $(0.36) per share from the same period last year.

Earnings

Earnings Beats

RANI

Rani Therapeutics Hldgs Q3 EPS $(0.24) Beats $(0.27) Estimate

IM Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(1.41) by 70.92 percent.

IMCC

IM Cannabis Q3 2024 Adj EPS $(0.41) Beats $(1.41) Estimate

UBS analyst Michael Goldsmith downgrades Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) from Buy to Neutral and lowers the price target from $155 to $134.

Downgrades

Price Target

Analyst Ratings

UBS Downgrades Sun Communities to Neutral, Lowers Price Target to $134

&nbsp;Enlivex Therapeutics Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLV#NASDAQ">ENLV</a>, the "Company"))), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for the first patient in its Phase I clinical trial evaluating the safety, tolerability and potential therapeutic effect of Allocetra&#x2122; following injection into an affected joint in patients with psoriatic arthritis. No safety concerns were recorded following the dosing of the first patient.
The trial currently plans to recruit six patients who have insufficiently responded to conventional therapies for psoriatic arthritis. The primary safety endpoint will measure the frequency and severity of adverse events and serious adverse events, and secondary endpoints will include assessments of change from baseline in pain and other parameters of disease activity for up to 12 months following administration of Allocetra&#x2122;.

Biotech

ENLV

Enlivex Announces The Dosing Of The First Patient In A Phase I Clinical Trial  Evaluating The Safety, Tolerability And Potential Therapeutic Effect Of Allocetra In Patients With Psoriatic Arthritis

Guidance

Management

ASML

ASML CEO, AT Investor Day, Says Sees Global Chip Market Growing 9% Annually And Passing $1T In 2030; Sees AI Chips Making Up 40% Of Total Market In 2030 After Rapid Growth

Expands Arabic Content With New Series And Exclusive Concerts, Partners With UAE Telcos For 4K Streaming And Saudi Ministry Of Culture For Talent Development

AAPL

Anghami Reports Strong 2024 Growth With 28% Increase In Video Streaming Engagement And 18% ARPU Rise; Launches AI-Driven Features, DolbyVision, And Apple Vision Pro App

Comments

FBR

News

Latest news for FBR (OTC:FBRKF) Stock

Tuesday, March 24, 2020

Friday, February 28, 2020

Tuesday, November 26, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga